These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 15515718

  • 1. [The economic and social costs of dementia].
    Washimi Y, Ohta T.
    Nihon Ronen Igakkai Zasshi; 2004 Sep; 41(5):451-9. PubMed ID: 15515718
    [No Abstract] [Full Text] [Related]

  • 2. Health economics: basic principles and application in mental health.
    Suh GH.
    Int Psychogeriatr; 2007 Dec; 19(6):993-1002. PubMed ID: 18161066
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.
    Behrens S, Rattinger GB, Schwartz S, Matyi J, Sanders C, DeBerard MS, Lyketsos CG, Tschanz JT.
    Int Psychogeriatr; 2018 Oct; 30(10):1499-1507. PubMed ID: 29559029
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Economics of dementia and pharmacoeconomics of dementia therapy.
    Fillit H, Hill J.
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):39-49. PubMed ID: 16089246
    [Abstract] [Full Text] [Related]

  • 7. The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.
    Wu G, Lanctôt KL, Herrmann N, Moosa S, Oh PI.
    CNS Drugs; 2003 Mar; 17(14):1045-57. PubMed ID: 14594444
    [Abstract] [Full Text] [Related]

  • 8. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S, Hill J, Fillit H.
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?
    Khang P, Weintraub N, Espinoza RT.
    J Am Med Dir Assoc; 2004 Jun; 5(4):249-55. PubMed ID: 15228635
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessing the societal impact of acetylcholinesterase inhibitor therapies.
    Winblad B, Wimo A.
    Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S9-19. PubMed ID: 10622674
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost of dementia in the pre-enlargement countries of the European Union.
    Luengo-Fernandez R, Leal J, Gray AM.
    J Alzheimers Dis; 2011 Nov; 27(1):187-96. PubMed ID: 21860095
    [Abstract] [Full Text] [Related]

  • 15. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Winblad B, Hill S, Beermann B, Post SG, Wimo A.
    Alzheimer Dis Assoc Disord; 1997 Nov; 11 Suppl 3():39-45. PubMed ID: 9305515
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness and cost-effectiveness of the pharmacological treatment of Alzheimer's disease and vascular dementia.
    Versijpt J.
    J Alzheimers Dis; 2014 Nov; 42 Suppl 3():S19-25. PubMed ID: 25061049
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacotherapy of patients with dementia].
    Hirsch RD.
    Internist (Berl); 2003 Dec; 44(12):1584-96. PubMed ID: 14689201
    [Abstract] [Full Text] [Related]

  • 19. Alzheimer's dementia: budget impact and cost-utility analysis of a combination treatment of a cholinesterase inhibitor and memantine in Switzerland.
    Pfeil AM, Kressig RW, Szucs TD.
    Swiss Med Wkly; 2012 Dec; 142():w13676. PubMed ID: 23180021
    [Abstract] [Full Text] [Related]

  • 20. Cholinesterase inhibitors in dementia: yes, no, or maybe?
    Lemstra AW, Richard E, van Gool WA.
    Age Ageing; 2007 Nov; 36(6):625-7. PubMed ID: 17881419
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.